As per MRFR analysis, the US Swab Market Size was estimated at 334.83 (USD Million) in 2023. The US Swab Market Industry is expected to grow from 357(USD Million) in 2024 to 823 (USD Million) by 2035. The US Swab Market CAGR (growth rate) is expected to be around 7.889% during the forecast period (2025 - 2035).
There are notable opportunities to be explored in the development of eco-friendly and biodegradable swabs, as the US increasingly emphasizes sustainability in healthcare. With state-level initiatives aimed at reducing plastic waste, manufacturers who pivot towards greener alternatives are likely to capture a growing segment of environmentally-conscious consumers. Furthermore, the compatibility of these swabs with a range of testing methods and protocols provides manufacturers with the chance to innovate and cater to niche markets within the healthcare industry. In recent times, the trend towards point-of-care testing has also gained momentum in the US, influenced by the need for immediate results during health emergencies.
This has led to an increased requirement for specific swab designs suitable for various testing formats, which directly impacts product development within the market. Participation in clinical trials and partnerships with healthcare providers can facilitate the swift adaptation of new technologies, signaling a trend toward collaboration within the sector. Overall, the US Swab Market is characterized by a responsive approach to healthcare needs and a strong commitment to innovation and sustainability.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The demand for diagnostic testing, particularly due to the increase in infectious diseases and ongoing public health initiatives, is a key driver for the US Swab Market Industry. The Centers for Disease Control and Prevention (CDC) has reported a 39% rise in testing rates for various infectious diseases over the last five years. This surge can be attributed to heightened awareness and the need for early detection, leading to a significant uptick in the utilization of swabs for testing.
Additionally, the COVID-19 pandemic has further amplified the use of swabs, as testing became a crucial part of public health strategy, as highlighted by the funding from the US government for increased laboratory testing capacity. As a result, healthcare providers are increasingly investing in swab technologies to enhance diagnostic accuracy, which is expected to further drive market growth in the future.
The ongoing expansion of healthcare infrastructure has a positive impact on the US Swab Market Industry. According to data from the American Hospital Association, there has been a significant increase in the number of healthcare facilities, with a rise of approximately 5% in accredited hospitals across the US over the past five years. This expansion includes the development of new outpatient facilities and specialized laboratories that enhance testing capabilities.
As these facilities emerge, there is a growing requirement for diagnostic supplies, including swabs, which are essential for patient testing. This infrastructure growth leads to increased procurement activities by healthcare providers, contributing to the overall market growth.
Technological advancements in the manufacturing of swabs are significantly propelling the growth of the US Swab Market Industry. Innovations such as the introduction of synthetic materials in swab production have improved the swabs' effectiveness in sample collection and reduced the risk of contamination. Manufacturers like Puritan Medical Products and Copan Diagnostics are investing heavily in Research and Development to enhance product quality and usability.
It is reported that products made with advanced materials can enhance sample yield by up to 25%, thereby improving diagnostic performance. The focus on developing more user-friendly swabs that satisfy regulatory standards ensures an expanding product portfolio, which is vital for the growth trajectory of the market.
The increasing incidence of chronic and infectious diseases is driving the demand for swab testing within the US Swab Market Industry. Data from the National Center for Health Statistics indicates that conditions such as diabetes and respiratory diseases have seen prevalence rates rising, with approximately 10% of the US population diagnosed with diabetes and respiratory infections accounting for a significant portion of hospital visits. Furthermore, the rise in antibiotic-resistant infections necessitates accurate testing, bolstering the requirement for reliable diagnostics using swabs.
Healthcare providers must engage more in diagnostic testing to manage and monitor these conditions effectively, leading to sustained growth in the swab market.
It allows for accurate identification of genetic disorders and helps in tailoring treatment plans, making it an essential tool in modern healthcare. Meanwhile, Urine tests are extensively used for screening and monitoring diverse health conditions, including infections, metabolic disorders, and kidney issues; its non-invasive nature contributes to its widespread use and cost-effectiveness. Saliva testing, on the other hand, is emerging as a convenient alternative with a growing role in drug testing, hormone level assessments, and infectious disease diagnosis. This method offers ease of sample collection and storage, making it attractive for both patients and healthcare providers. Other testing methods continue to evolve, adding diversity to the market landscape.
Factors such as increasing healthcare awareness, innovation in diagnostic technologies, and a rise in chronic disease prevalence are fueling the growth of the 'US Swab Market.' The market is expected to respond positively to these trends, unlocking numerous opportunities for stakeholders. As healthcare systems increasingly seek to enhance patient outcomes through accurate and rapid diagnostics, the significance of these various test types within the 'US Swab Market' is likely to grow, reflecting a broader shift towards personalized and precision medicine. Overall, the Test Type segment is well-positioned to address the evolving needs of healthcare providers and patients alike in the US, fostering further development and investment in innovative swab testing solutions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Cotton swabs are widely utilized due to their versatility and are often favored in both household uses and professional settings. Dry and gauze swabs play a crucial role in wound care and hygiene, demonstrating their importance in healthcare environments. The 'Others' category encompasses a variety of specialty swabs designed for specific tasks, contributing to the market's overall diversity. As the US shifts towards greater health awareness and hygiene practices, the demand for all these segments is expected to rise, driven by trends in healthcare innovation, increased consumer awareness, and the growing emphasis on infection control measures in both clinical and home settings. Understanding the dynamics of the US Swab Market segmentation can provide valuable insights into consumer behavior and market trends, as well as inform strategic decisions for manufacturers and stakeholders.
Laboratory applications are critical as swabs are essential tools for specimen collection and diagnostics, allowing for comprehensive analytical testing. Additionally, the Others segment encompasses uses in areas such as forensic science and personal care, reflecting the market's versatility. Notably, the integration of advanced technologies in swab production is improving efficiency and accuracy across these applications. With robust growth drivers, including increasing healthcare spending and the need for infection control, the US Swab Market segmentation indicates substantial opportunities for innovation and expansion within these domains.
On the other hand, Polypropylene shafts present excellent chemical resistance and flexibility, catering to specific applications in sample collection and cleaning routines. The Swab Market segmentation also includes other materials that play unique roles, ensuring a diversified approach to meeting varying consumer needs. Recent trends indicate a growing demand for eco-friendly and sustainable materials, pushing manufacturers to innovate in the Shaft segment. Moreover, government investments in healthcare infrastructure and rising awareness regarding hygiene and infection control are expected to further enhance the market's growth potential. Overall, the ongoing advancements in technology and material science are likely to lead to a notable shift in the preferences and demands in this segment, directly contributing to the broader US Swab Market statistics and trends.
The US Swab Market presents a dynamic landscape characterized by a variety of players and an increasing demand for swab solutions in various applications such as diagnostics, healthcare, and personal care. The market is witnessing a surge in interest due to the growing emphasis on hygiene, infection control, and innovative diagnostic methods. Competitive insights reveal that companies are focusing on enhancing their product offerings, improving performance, and expanding their market reach through strategic partnerships, investments in research and development, and targeted marketing campaigns. This competitive environment necessitates a strong understanding of market trends and customer preferences, enabling players to position themselves effectively and capture a significant share of the market.
Eppendorf stands out in the US Swab Market with a robust presence and a reputation for delivering high-quality products that cater to various laboratory and clinical needs. The company’s strengths lie in its commitment to innovation and excellence, underscored by a diverse array of swab products designed for superior performance. Eppendorf emphasizes precision engineering and user-friendly design, ensuring that their swabs meet the rigorous standards of practice in the healthcare and research sectors. The company benefits from a strong brand recognition and a loyal customer base, which is integral to its success in the competitive landscape of the US Swab Market. Eppendorf’s focus on research and development allows it to continuously enhance its product line, aligning it closely with the evolving demands of the market.
Halyard Health has established a solid foothold in the US Swab Market, recognized for its commitment to quality and effectiveness in infection prevention and control. The company specializes in a range of swabs tailored for healthcare applications, such as sampling for diagnostics and sterile procedures. Halyard Health's strengths include its extensive experience and expertise within the healthcare sector, bolstered by a portfolio of innovative products designed to enhance patient safety and clinician efficiency. The company actively pursues growth strategies through mergers and acquisitions, which enable it to expand its product offerings and market reach. Key products include a variety of sterile swabs and antimicrobial solutions aimed at reducing the risk of healthcare-associated infections. Halyard Health's strategic initiatives and strong customer relationships position it favorably within the competitive US Swab Market, facilitating the delivery of quality solutions to meet the needs of healthcare providers throughout the region.
The US Swab Market has witnessed significant developments recently, particularly as the demand for COVID-19 testing swabs remains high. In October 2023, Puritan Medical Products announced expansion plans to increase swab production capacity in response to ongoing public health needs. Eppendorf is focusing on enhancing the quality and functionality of their liquid handling equipment, aiding laboratory swab testing processes. In terms of mergers and acquisitions, Halyard Health acquired certain assets from a rival firm in August 2023, strengthening its position in the medical supply industry, particularly for swabs used in diagnostics.
Furthermore, the FDA continues to emphasize the importance of quality control in swab manufacturing, which influences companies like Becton Dickinson and Thermo Fisher Scientific in maintaining stringent production standards. The market's growth is reflected in the increasing revenue reports from key players, with an uptick in valuation observed in BioRad Laboratories and Abbott Laboratories. Over the last couple of years, heightened awareness and emphasis on hygiene due to the pandemic have dramatically increased the usage of medical swabs across healthcare facilities in the US, thus significantly impacting the overall market trajectory.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 334.83(USD Million) |
| MARKET SIZE 2024 | 357.0(USD Million) |
| MARKET SIZE 2035 | 823.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.889% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Eppendorf, Halyard Health, Randox Laboratories, Puritan Medical Products, RayBiotech, Medline Industries, Cypress Diagnostics, BioRad Laboratories, Becton Dickinson, Thermo Fisher Scientific, Fisher Scientific, Abbott Laboratories, Greiner BioOne, Biosafe, Cardinal Health |
| SEGMENTS COVERED | Test Type, Product, Application, Shaft |
| KEY MARKET OPPORTUNITIES | Increased demand for COVID testing, Rising applications in diagnostics, Innovations in biodegradable materials, Expansion in home healthcare, Growth of telemedicine services |
| KEY MARKET DYNAMICS | increasing hygiene awareness, rising healthcare expenditure, technological advancements in swab designs, growing demand for diagnostics, expansion of distribution channels |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Swab Market is expected to be valued at 357.0 million USD in 2024.
By 2035, the US Swab Market is projected to reach a valuation of 823.0 million USD.
The expected CAGR for the US Swab Market from 2025 to 2035 is 7.889%.
The DNA testing swab type is anticipated to hold the largest market share, valued at 100.0 million USD in 2024.
The urine test swab segment is valued at 90.0 million USD in 2024.
The saliva test segment is expected to grow to 185.0 million USD by 2035 from 85.0 million USD in 2024.
Key players in the US Swab Market include Eppendorf, Halyard Health, Puritan Medical Products, and Becton Dickinson.
The 'Others' segment of the US Swab Market is expected to reach 208.0 million USD by 2035.
Challenges that may affect growth include regulatory changes and competition among manufacturers.
Advancements in technology are enhancing accuracy and efficiency, thereby driving growth in the US Swab Market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
